Last checked at 15 Sep 2015 15:02
15th September 2015
Voting Rights and Capital
In conformity with the Transparency Directive's provision 5.6.1, Spirax-Sarco Engineering plc makes the following disclosure with respect to share capital and voting rights.
On 31st December 2014 Spirax-Sarco Engineering plc's capital consisted of 73,310,297 ordinary shares with voting rights. Spirax-Sarco Engineering plc holds no shares in Treasury.
The total number of voting rights in Spirax-Sarco Engineering plc is 73,310,297.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Spirax-Sarco Engineering plc under the FSA's Disclosure and Transparency Rules.
Enquiries:
Andy Robson, General Counsel & Company Secretary
Tel: 01242 535276
About Spirax Sarco
Spirax-Sarco Engineering plc is the world leader in each of its two businesses, steam specialties and peristaltic and niche pumping. The steam specialties business provides a broad range of fluid control products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The company helps its customers to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow is the global leader in peristaltic pumps, specialising in the design and manufacture of the most advance peristaltic and niche pumps, and tubing. Watson-Marlow pumps offer the ideal solution for a wide variety of difficult pumping applications and are highly accurate, controllable and virtually maintenance free. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,700 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com